Rocket Pharmaceuticals Inc
Officers & Directors
1. Gaurav Shah - CEO and President - Gaurav Shah is a medical doctor, entrepreneur, and venture capitalist with more than 20 years of experience in the biotech industry. Prior to joining Rocket Pharmaceuticals, he was a managing director at the private equity firm RA Capital. 2. Kinnari Patel e CFO - Kinnari Patel has been the Chief Financial Officer of Rocket Pharmaceuticals since . Before joining Rocket Pharmaceuticals, she worked in the Healthcare Investment Banking Group at Citigroup. 3. Gayatri Rao - CMO - Dr. Gayatri Rao is a board-certified Physician and Hematology/Oncology specialist with more than 20 years of experience in clinical development and medical affairs. She served at the US FDA as the Director of the Office of Orphan Products Development. 4. Jonathan Schwartz - CDO - Jonathan Schwartz is a former executive at the pharmaceutical giant Pfizer, where he was responsible for the companyes global gene therapy portfolio. 5. Stephen Schuster - Director - Stephen Schuster is a Professor of Medicine at the University of Pennsylvania, where he leads the Lymphoma Program. 6. William Lis - Director - William Lis is the founder and CEO of PharmIdeas, a healthcare consulting firm. He is also a board member of other healthcare companies. Caroline Tissot - Director - Caroline Tissot is the Chief Corporate Affairs Officer at the pharmaceutical company Ipsen. She has more than 20 years of experience in corporate communications and investor relations. 8. Wendy K. Goldberg - Director - Wendy K. Goldberg is the Executive Vice President and Chief Financial Officer of Xconomy. She has more than 25 years of experience in finance and accounting.
Rocket Pharmaceuticals Inc currently has 202 employees.
News about Rocket Pharmaceuticals Inc Key Personnel |
Rocket Pharmaceuticals Inc. has recently made significant changes to its corporate leadership team, with the appointment of Aaron Ondrey as Chief Financial Officer (CFO). The company, a leading late-stage biotechnology firm focused on developing genetic therapies for rare disorders, aims to strengthen its position in the market and meet the high unmet medical needs of patients.
The appointment of Aaron Ondrey as CFO indicates Rocket Pharmaceuticals commitment to ensuring financial stability and sustainable growth. With his extensive experience and expertise in financial management, Ondrey will play a vital role in overseeing the company s financial operations and shaping its financial strategy...
|
|
